News

Stevanato Group, through Ompi, its specialist in glass primary packaging for the pharmaceutical industry, and Bormioli Pharma announce today a collaboration agreement. The agreement…
Read More...

LSNE Contract Manufacturing broke ground on a 26,000 square foot addition of its existing 7 Commerce facility on the Bedford, New Hampshire campus. This expansion further increases…
Read More...

ACG Inspection - one of the four businesses of ACG Group, the only supplier in the world offering end-to-end manufacturing solutions for the pharmaceutical industry - has introduced an…
Read More...

Assertio Therapeutics announced it has entered into a definitive agreement with Collegium Pharmaceutical, Inc. pursuant to which Collegium will acquire the NUCYNTA franchise of products…
Read More...

Aimmune Therapeutics announced that Nestlé Health Science will make an additional equity investment in Aimmune of $200 million, bringing Nestlé’s total investment in Aimmune to date to…
Read More...

ReAlta Life Sciences announced that U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to PIC1-dPEG24 for the treatment of hypoxic-ischemic encephalopathy (HIE)…
Read More...

Italian-based Stevanato Group, a leading producer of glass primary packaging and provider of integrated capabilities for combination products and the US-based Pfeiffer Vacuum…
Read More...

Immix Biopharma, Inc., announced that the first patient in the USA was dosed successfully in its flagship phase 1b/2a clinical trial testing Imx-110 in patients with refractory solid…
Read More...

Rebiotix, a Ferring company, announced that it has completed enrollment of the pivotal Phase 3 clinical trial for RBX2660, an investigational therapy aimed at breaking the cycle of…
Read More...

BioMotiv and Bristol-Myers Squibb Company announced the launch of Anteros Pharmaceuticals, a biotechnology company focused on developing a new class of drugs for fibrotic and other…
Read More...

Regeneron Pharmaceuticals announced an expanded agreement with the U.S. Department of Health and Human Services (HHS) to develop new treatments combating the novel coronavirus,…
Read More...

Horses with severe equine asthma struggle to breath, even at rest. This week, the European Commission granted marketing authorization1 to Boehringer Ingelheim for the new Aservo…
Read More...

Navrogen, Inc., a biopharmaceutical company specialized in developing therapies for cancer and immune-related disorders, and Levena Biopharma, a company specialized in developing…
Read More...

Teva Pharmaceutical Industries Ltd. announced positive results from two Phase 2/3 trials evaluating AJOVY (fremanezumab) in patients in Japan. AJOVY is under development in Japan by…
Read More...

Merck, known as MSD outside the United States and Canada, announced that the U.S. Food and Drug Administration (FDA) has accepted for review a supplemental New Drug Application (sNDA)…
Read More...

BetterLife Pharma Inc. announced the acquisition of Swiss based Solmic AG with its strong IP portfolio including unique formulation technology for the production of stable micelles…
Read More...

Applied BioMath, the industry-leader in applying systems pharmacology and mechanistic modeling, simulation, and analysis to de-risk drug research and development, announced a…
Read More...

Avacta Group plc , the developer of Affimer biotherapeutics and reagents, is pleased to announce that it has signed a collaboration and license agreement with AffyXell Therapeutics, the…
Read More...

Catalent and MaSTherCell Global announced that Catalent has agreed to acquire MaSTherCell Global, a company backed by Great Point Partners, SFPI-FPIM, and Orgenesis Inc. for an…
Read More...

Seqirus announced that the U.S. Food and Drug Administration (FDA) has approved AUDENZ (Influenza A (H5N1) Monovalent Vaccine, Adjuvanted) to help protect individuals six months of age…
Read More...